Determination of isoniazid, acetylisoniazid, acetylhydrazine and diacetylhydrazine in biological fluids by high-performance liquid chromatography

A high-performance liquid chromatographic assay for the determination of isoniazid, acetylisoniazid, acetylhydrazine and diacetylhydrazine (plasma and urine) was developed. The m-chlorobenzoyl derivatives of isoniazid, acetylhydrazine and the internal standard propionylhydrazine were prepared, separated on a RP-18 column and detected at 220 nm. Acetylisoniazid, diacetylhydrazine and the internal standard dipropionylhydrazine were converted to isoniazid, acetylhydrazine, and propionylhydrazine by acidic hydrolysis and subsequently derivatized with m-fluorobenzoyl chloride, separated on a RP-18 column and detected at 220 nm. The lower limits of detection in plasma are acetylhydrazine 0.5 nmol/ml, isoniazid 1.0 nmol/ml, diacetylhydrazine 1.0 nmol/ml and acetylisoniazid 2.0 nmol/ml, and in urine, acetylhydrazine 10 nmol/ml, isoniazid 15 nmol/ml, diacetylhydrazine 20 nmol/ml and acetylisoniazid 40 nmol/ml. This method is sensitive, reproducible, accurate and precise; therefore, it is well suited for detailed pharmacokinetic studies.     

Reaktionen mit γ-Chloracetessigesterderivaten

Reactions with derivatives of γ-chloroacetoacetic acid Ethyl γ-chloroacetoacetate reacts with ammonia to give ethyl β-amino-γ-chloro-crotonate; with aniline, however, β-anilino-crotonic acid γ-lactone is formed. The reaction of ethyl α-cyano-γ-chloro-acetoacetate with arylamines yields 1-aryl-2-amino-3-ethoxycarbonyl-pyrrolin-4-ones.     

A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterised by selective neuronal death in the brain stem and spinal cord. The cause is unknown, but an increasing amount of evidence has firmly certified that neuroinflammation plays a key role in ALS pathogenesis. Neuroinflammation is a pathological hallmark of several neurodegenerative disorders and has been implicated as driver of disease progression. Here, we describe a treatment study demonstrating the therapeutic potential of a tandem version of the well-known all-d-peptide RD2 (RD2RD2) in a transgenic mouse model of ALS (SOD1*G93A). Mice were treated intraperitoneally for four weeks with RD2RD2 vs. placebo. SOD1*G93A mice were tested longitudinally during treatment in various behavioural and motor coordination tests. Brain and spinal cord samples were investigated immunohistochemically for gliosis and neurodegeneration. RD2RD2 treatment in SOD1*G93A mice resulted not only in a reduction of activated astrocytes and microglia in both the brain stem and lumbar spinal cord, but also in a rescue of neurons in the motor cortex. RD2RD2 treatment was able to slow progression of the disease phenotype, especially the motor deficits, to an extent that during the four weeks treatment duration, no significant progression was observed in any of the motor experiments. Based on the presented results, we conclude that RD2RD2 is a potential therapeutic candidate against ALS.     

The K<Superscript>-</Superscript>α scattering length and the reaction dd↦αK<Superscript>+</Superscript>K<Superscript>-</Superscript>

We present predictions for the K^-α scattering length obtained within the framework of the multiple-scattering approach. Evaluating the pole position of the K^-α scattering amplitude within the zero-range approximation, we find a loosely bound K^-α state with a binding energy of E_R = - 2,..., - 7 MeV and a width Γ_R = 11,..., 18 MeV. We propose to measure the K^-α scattering length through the final-state interaction between the α and K^--meson produced in the reaction dd↦αK⁺K^-. It is found that the K^-α invariant-mass distribution from this reaction at energies near the threshold provides a new tool to determine the s-wave K^-α scattering length.     

Synthesen und Eigenschaften von Tris(perfluoralkyl)arsen- und -antimon(III,V)-Verbindungen

Preparations and Properties of Tris(perfluoroalkyl) Arsenic and Antimony(III, V) Compounds As(R_f)₃ and Sb(R_f)₃ (R_f?C₂F₅, C₄F₉, C₆F₁₃) are prepared in good yields by the polar reactions of AsCl₃ and SbCl₃ with bis(perfluoroalkyl) cadmium compounds as colourless liquids or solids. The oxidation of As(C₂F₅)₃ and Sb(C₂F₅)₃ with XeF₂ gives the difluorides M(C₂F₅)₃F₂ (M?As, Sb). As(C₂F₅)₃Cl₂ is prepared by chlorination of As(C₂F₅)₃ in the presence of AlCl₃, while Sb(C₂F₅)₃Cl₂ is formed in the reaction of Sb(C₂F₅)₃F₂ with (CH₃)₃SiCl. During the reaction of M(C₂F₅)₃F₂ with (CH₃)₃SiBr ¹⁹F-NMR spectroscopic evidence is found for M(C₂F₅)₃ Br₂. The thermal decompositions of M(C₂F₅)₃F₂ mainly yield C₄F₁₀ and M(C₂F₅)F₂, while the thermal decompositions of M(C₂F₅)₃Cl₂ yield M(C₂F₅)₂Cl and C₂F₅Cl. The properties and spectroscopic data of the new compounds are described.     

A Korn's inequality for incompatible tensor fields

We prove a Korn-type inequality for bounded Lipschitz domains in and non-symmetric square integrable tensor fields having square integrable rotation . For skew-symmetric P or compatible our estimate reduces to non-standard variants of Poincaré's or Korn's first inequality, respectively, for which our new estimate can be viewed as a common generalized version. (© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim)